A mega-analysis of genome-wide association studies for major depressive disorder.

Authors:

Mol Psychiatry 2013 Apr 3;18(4):497-511. Epub 2012 Apr 3.

Harvard University/Broad Institute, USA.

Prior genome-wide association studies (GWAS) of major depressive disorder (MDD) have met with limited success. We sought to increase statistical power to detect disease loci by conducting a GWAS mega-analysis for MDD. In the MDD discovery phase, we analyzed more than 1.2 million autosomal and X chromosome single-nucleotide polymorphisms (SNPs) in 18 759 independent and unrelated subjects of recent European ancestry (9240 MDD cases and 9519 controls). In the MDD replication phase, we evaluated 554 SNPs in independent samples (6783 MDD cases and 50 695 controls). We also conducted a cross-disorder meta-analysis using 819 autosomal SNPs with P<0.0001 for either MDD or the Psychiatric GWAS Consortium bipolar disorder (BIP) mega-analysis (9238 MDD cases/8039 controls and 6998 BIP cases/7775 controls). No SNPs achieved genome-wide significance in the MDD discovery phase, the MDD replication phase or in pre-planned secondary analyses (by sex, recurrent MDD, recurrent early-onset MDD, age of onset, pre-pubertal onset MDD or typical-like MDD from a latent class analyses of the MDD criteria). In the MDD-bipolar cross-disorder analysis, 15 SNPs exceeded genome-wide significance (P<5 × 10(-8)), and all were in a 248 kb interval of high LD on 3p21.1 (chr3:52 425 083-53 822 102, minimum P=5.9 × 10(-9) at rs2535629). Although this is the largest genome-wide analysis of MDD yet conducted, its high prevalence means that the sample is still underpowered to detect genetic effects typical for complex traits. Therefore, we were unable to identify robust and replicable findings. We discuss what this means for genetic research for MDD. The 3p21.1 MDD-BIP finding should be interpreted with caution as the most significant SNP did not replicate in MDD samples, and genotyping in independent samples will be needed to resolve its status.

Download full-text PDF

Source
http://dx.doi.org/10.1038/mp.2012.21DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837431PMC
April 2013
76 Reads
347 Citations
14.500 Impact Factor

Publication Analysis

Top Keywords

mdd cases
8
genome-wide association
8
major depressive
8
depressive disorder
8
association studies
8
mdd
6
analyzed autosomal
4
phase analyzed
4
samples 6783
4
autosomal chromosome
4
chromosome single-nucleotide
4
single-nucleotide polymorphisms
4
independent samples
4
discovery phase
4
mdd discovery
4
conducting gwas
4
mdd replication
4
gwas mega-analysis
4
mega-analysis mdd
4
6783 mdd
4

References

(Supplied by CrossRef)

DS Hasin et al.
Arch Gen Psychiatry 2005

RC Kessler et al.
JAMA 2003

TI Mueller et al.
Am J Psychiatry 1999

LL Judd et al.
Arch Gen Psychiatry 1997

AD Lopez et al.
Lancet 2006

HU Wittchen et al.
Eur Neuropsychopharmacol 2011

F Angst et al.
J Affective Disord 2002

A Gustavsson et al.
Eur Neuropsychopharmacol 2011

CJL Murray et al.
Science 1996

PF Sullivan et al.
Am J Psychiatry 2000

DF Levinson et al.
Biol Psychiatry 2006

Similar Publications